http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-143477-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07b71571160c289fbf5fc680dfea513f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
filingDate 2003-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c54ffd867065e8d8157cfaded10c832b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b00ee5f521ac905e4a56b38596b7a564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_785dd298a1e7611d634b654715f65a76
publicationDate 2011-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MY-143477-A
titleOfInvention Il-8 receptor antagonists
abstract THIS INVENTION RELATES TO NOVEL COMPOUNDS OF FORMULA (I) TO (VII), AND COMPOSITIONS THEREOF, USEFUL IN THE TREATMENT OF DISEASE STATES MEDIATED BY THE CHEMOKINE, INTERLEUKIN-8 (IL-8).
priorityDate 2002-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44357137
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP79255
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP46653
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP41324
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49113
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP26894
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ102R3
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396495
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID493836
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3576
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7YRB5
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396880
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP10145
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08317
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280828
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403850
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO62812
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19874
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9XSX5
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP67814
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP67813
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100002946
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP36925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426343843

Total number of triples: 58.